World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
52
Citations
14816
World Ranking
4164
National Ranking
1612

Anthony L. DeVico publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Anthony L. DeVico sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 175 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Anthony L. DeVico D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Anthony L. DeVico sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 52 D-Index — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Anthony L. DeVico is affiliated with the University of Maryland, Baltimore in the United States. Their research spans the fields of Medicine and Immunology and Microbiology, with a focus on several specialized subfields including Radiology, Nuclear Medicine and Imaging, Infectious Diseases, Molecular Biology, Virology, and Immunology.

The scientist's work covers a range of topics primarily centered on Monoclonal and Polyclonal Antibodies Research, HIV Research and Treatment, and SARS-CoV-2 and COVID-19 Research. Additional research interests include Glycosylation and Glycoproteins Research, Protein purification and stability, HIV/AIDS drug development and treatment, and SARS-CoV-2 detection and testing.

Among the more frequently published venues for their work are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Structure
  • Journal of Virology
  • PLoS ONE
  • Acta Biomaterialia

Notable recent papers by Anthony L. DeVico include:

  • Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays, 2020, PLoS ONE
  • Antigen-Induced Allosteric Changes in a Human IgG1 Fc Increase Low-Affinity Fcγ Receptor Binding, 2020, Structure
  • Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studies, 2022, Journal of Translational Medicine
  • Evidence of variable human Fcγ receptor-Fc affinities across differentially-complexed IgG, 2023, mAbs

Frequent collaborators include Mohammad M. Sajadi, George K. Lewis, Alonso Heredia, Zahra Rikhtegaran Tehrani, and Ben Atkinson, reflecting ongoing partnerships in their research projects.

Best Publications

  • Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells

    Fiorenza Cocchi;Anthony L. DeVico;Alfredo Garzino-Demo;Suresh K. Arya

  • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner

  • Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV

    F. Di Marzo Veronese;T. D. Copeland;A. L. Devico;Rukhsana Rahman

  • The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection

    Florenza Cocchi;Anthony L. DeVico;Alfredo Garzino-Demo;Andrea Cara

  • Characterization of gp41 as the Transmembrane Protein Coded by the HTLV-III/LAV Envelope Gene

    Fulvia DiMarzo Veronese;Anthony L. DeVico;Terry D. Copeland;Stephen Oroszlan

  • Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family

    Mattia Bonsignori;Justin Pollara;M. Anthony Moody;Michael D. Alpert

  • Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M.

    Bala Chandran Nair;Anthony L. DeVico;Shuji Nakamura;Terry D. Copeland

  • Inhibition of HIV-1 Infection by the β-Chemokine MDC

    Ranajit Pal;Alfredo Garzino-Demo;Phillip D. Markham;Jennifer Burns

  • Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro

    H Mitsuya;R F Jarrett;M Matsukura;F Di Marzo Veronese

  • Higher macrophage inflammatory protein (MIP)-1α and MIP-1β levels from CD8+ T cells are associated with asymptomatic HIV-1 infection

    Fiorenza Cocchi;Anthony L. DeVico;Robert Yarchoan;Robert Redfield

  • Spontaneous and antigen-induced production of HIV-inhibitory β-chemokines are associated with AIDS-free status

    Alfredo Garzino-Demo;Ronald B. Moss;Joseph B. Margolick;Farley Cleghorn

  • Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques.

    Timothy Fouts;Karla Godfrey;Kathryn Bobb;David Montefiori

  • Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding

    Yongjun Guan;Marzena Pazgier;Mohammad M. Sajadi;Roberta Kamin-Lewis

  • Expression and Characterization of a Single-Chain Polypeptide Analogue of the Human Immunodeficiency Virus Type 1 gp120-CD4 Receptor Complex

    Timothy R. Fouts;Robert Tuskan;Karla Godfrey;Marvin Reitz

  • Control of HIV-1 infection by soluble factors of the immune response

    Anthony L. DeVico;Robert C. Gallo

  • Role of β-Chemokines in Suppressing HIV Replication

    C. E. Mackewicz;E. Barker;J. A. Levy;F. Cocchi

  • Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection

    Timothy R. Fouts;Kenneth Bagley;Ilia J. Prado;Kathryn L. Bobb

  • Human neutrophil α-defensin 4 inhibits HIV-1 infection in vitro

    Zhibin Wu;Fiorenza Cocchi;David Gentles;Bryan Ericksen

  • Antibody persistence and T-cell balance: Two key factors confronting HIV vaccine development

    George K. Lewis;Anthony L. DeVico;Robert C. Gallo

  • Structural Definition of an Antibody-Dependent Cellular Cytotoxicity Response Implicated in Reduced Risk for HIV-1 Infection.

    Priyamvada Acharya;William D. Tolbert;Neelakshi Gohain;Xueji Wu

  • Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment.

    Bruce L Gilliam;Alonso Heredia;Anthony DeVico;Nhut Le

Frequent Co-Authors

George K. Lewis
George K. Lewis University of Maryland, Baltimore
Robert C. Gallo
Robert C. Gallo University of South Florida
Robert R. Redfield
Robert R. Redfield Centers for Disease Control and Prevention
Ranajit Pal
Ranajit Pal Advanced Bioscience Laboratories (United States)
M. G. Sarngadharan
M. G. Sarngadharan AkzoNobel (Netherlands)
David C. Montefiori
David C. Montefiori Duke University
Michael S. Seaman
Michael S. Seaman Beth Israel Deaconess Medical Center
Georgia D. Tomaras
Georgia D. Tomaras Duke University
Paolo Lusso
Paolo Lusso National Institutes of Health
Marvin S. Reitz
Marvin S. Reitz University of Maryland, Baltimore

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology opens doors to diverse career paths, not just in traditional lab roles but also emerging fields that blend healthcare and technology. One growing area is health information management, where professionals manage patient data and healthcare systems. Exploring a health information management job description and salary can provide valuable insight into these opportunities.

For students interested in quickly entering the workforce, pursuing a certification through fast online medical billing and coding certification programs offers a streamlined pathway. These certifications prepare graduates for roles including Certified Professional Coder (CPC), which are in demand across medical settings.

Understanding the role and compensation of certified coders is essential. The cpc salary reflects competitive wages and growth potential in the field.

If you're considering a degree program, selecting accredited options ensures quality education and better job prospects. The list of best online health information management degree cahiim accredited programs can help prospective students find reputable courses aligned with industry standards.

Best Scientists Citing Anthony L. DeVico

Trending Scientists

Recently Published Articles